White Oak Capital - Pharma and Healthcare Fund · Regular · Growth
NAV
₹16.5540
as of 31 Jul 2026
Expense Ratio
2.37%
AUM
₹642 Cr
Lumpsum returns (CAGR)
- 1Y
- +17.02%
- 3Y
- —
- 5Y
- —
- Since Inception
- +21.97%
SIP returns (XIRR)
- 1Y
- +32.53%
- 3Y
- —
- 5Y
- —
- Since Inception
- +22.59%
Returns calculated from 16 January 2024 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
We don't show backtest scenarios for this fund yet — its NAV history has an unresolved discontinuity we're still verifying. Returns above are unaffected.
Risk Metrics
Trailing 1 year, annualised0.68
Sharpe Ratio
+0.15
Alpha
0.23
Beta
0.65
Sortino
14.46%
Std Dev
-11.94%
Max Drawdown
Performance Comparison
Thinking about White Oak Capital - Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Investment Objective
White Oak Capital - Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
White Oak Capital - Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by WhiteOak Capital Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹642 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.37%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations